Influenza Immunization

Infectious Disease·MeSH: Influenza, Human

28 drugs in development·2 companies·16 clinical trials

Drug Pipeline by Phase

Phase 3(10)

Drug	Company
high-dose influenza vaccine (split virion	Sanofi (SNY)
high-dose quadrivalent influenza vaccine	Sanofi (SNY)
Purified inactivated rabies vaccine - Imovax® Rabies	Sanofi (SNY)
Purified inactivated rabies vaccine - Verorab®	Sanofi (SNY)
quadrivalent influenza standard dose vaccine	Sanofi (SNY)
quadrivalent influenza vaccine	Sanofi (SNY)
recombinant influenza vaccine	Sanofi (SNY)
standard-dose influenza virus surface antigens	Sanofi (SNY)
TEV-48574 Dose Regimen A	Sanofi (SNY)
trivalent recombinant influenza vaccine	Sanofi (SNY)

Phase 2(2)

Drug	Company
covid-19 mrna vaccine	Sanofi (SNY)
TEV-48574 Dose Regiment B	Sanofi (SNY)

Phase 1(4)

Drug	Company
h3 mrna / lnp vaccine	Sanofi (SNY)
high dose quadrivalent influenza vaccine	Sanofi (SNY)
mrna na vaccine	Sanofi (SNY)
quadrivalent recombinant influenza vaccine	Sanofi (SNY)

Unknown(3)

Phase 1/Phase 2(7)

Drug	Company
pandemic flu h5 ha mrna sd2 vaccine	Sanofi (SNY)
pandemic flu h5 mrna vaccine	Sanofi (SNY)
quadrivalent influenza high-dose vaccine	Sanofi (SNY)
quadrivalent influenza mrna vaccine mrt5421	Sanofi (SNY)
quadrivalent influenza mrna vaccine mrt5424	Sanofi (SNY)
quadrivalent influenza mrna vaccine mrt5429	Sanofi (SNY)
tiv mrna-neuraminidase	Sanofi (SNY)

Phase 4(2)

Drug	Company
fluzone high-dose quadrivalent vaccine	Sanofi (SNY)
fluzone quadrivalent vaccine	Sanofi (SNY)

BioSniper tracks 28 drugs in development for Influenza Immunization across 2 companies.

There are 16 clinical trials targeting Influenza Immunization tracked by BioSniper.

Full trial data, competitive analysis, and AI-powered pipeline tracking.